MedTrace Logo

Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer

NCT03853733 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-03-19

No results posted yet for this study

Summary

Many patients with rectal cancer were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases. In this scenario only comfort measures or different palliative radiotherapy regimens are applied, from single doses to treatments lasting several weeks. The aim of this prospective study is to describe the preliminary results of our protocol of hypofractionated palliative radiotherapy in patients with non-operable rectal cancer.

Conditions

Interventions

RADIATION

rectal cancer radiotherapy

Conformal three-dimensional radiotherapy to deliver to the primary tumor and the enlarged pelvic nodes a total dose of 39Gy in 13 sessions of 3Gy in 17 days.

Sponsors & Collaborators

  • Consorci Sanitari de Terrassa

    lead OTHER

Principal Investigators

  • Joan Lozano, MD · Consorci Sanitari de Terrassa

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2027-03-01
Completion
2027-03-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853733 on ClinicalTrials.gov